A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders

Omotayo, OPLemmer, YolandyMason, S2024-07-222024-07-222024-03Omotayo, O., Lemmer, Y. & Mason, S. 2024. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. Journal of Cannabis Research, 14(6). http://hdl.handle.net/10204/137242522-5782https://doi.org/10.1186/s42238-024-00222-2http://hdl.handle.net/10204/13724The treatment of diverse diseases using plant-derived products is actively encouraged. In the past few years, cannabidiol (CBD) has emerged as a potent cannabis-derived drug capable of managing various debilitating neurological infections, diseases, and their associated complications. CBD has demonstrated anti-inflammatory and curative effects in neuropathological conditions, and it exhibits therapeutic, apoptotic, anxiolytic, and neuroprotective properties. However, more information on the reactions and ability of CBD to alleviate brain-related disorders and the neuroinflammation that accompanies them is needed.FulltextenCannabis researchCannabidiolCBDBrain-related disordersA narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disordersArticleOmotayo, O., Lemmer, Y., & Mason, S. (2024). A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. Journal of Cannabis Research, 14(6), http://hdl.handle.net/10204/13724Omotayo, OP, Yolandy Lemmer, and S Mason "A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders." Journal of Cannabis Research, 14(6) (2024) http://hdl.handle.net/10204/13724Omotayo O, Lemmer Y, Mason S. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. Journal of Cannabis Research, 14(6). 2024; http://hdl.handle.net/10204/13724.TY - Article AU - Omotayo, OP AU - Lemmer, Yolandy AU - Mason, S AB - The treatment of diverse diseases using plant-derived products is actively encouraged. In the past few years, cannabidiol (CBD) has emerged as a potent cannabis-derived drug capable of managing various debilitating neurological infections, diseases, and their associated complications. CBD has demonstrated anti-inflammatory and curative effects in neuropathological conditions, and it exhibits therapeutic, apoptotic, anxiolytic, and neuroprotective properties. However, more information on the reactions and ability of CBD to alleviate brain-related disorders and the neuroinflammation that accompanies them is needed. DA - 2024-03 DB - ResearchSpace DP - CSIR J1 - Journal of Cannabis Research, 14(6) KW - Cannabis research KW - Cannabidiol KW - CBD KW - Brain-related disorders LK - https://researchspace.csir.co.za PY - 2024 SM - 2522-5782 T1 - A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders TI - A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders UR - http://hdl.handle.net/10204/13724 ER -28075